Answers are grounded in this paper and cite their sources.
High‐throughput imaging is needed to identify rare diseased cells among a large population of healthy cells. When combined with microfluidics, this labelfree cell identification method can revolutionize pathology, cancer screening, and potentially even stem cell therapy. Featuring optical image streaming and amplification, this new approach to imaging overcomes the technological and fundamental limits of the classic image sensor technology and may represent the solution.
No takes yet. Share an insight, caveat, or question.
Jalali et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: